Journal of Peking University(Health Sciences) >
Urodynamic and histological evaluation of cyclophosphamide-induced bladder pain syndrome in SD rats
Received date: 2022-03-16
Online published: 2022-08-11
Supported by
the National Natural Science Foundation of China(81970660)
Objective: To establish a model of bladder pain syndrome in SD rats by cyclophosphamide intraperitoneal injection, to evaluate the effectiveness of the model from the urodynamic and histological levels, to lay a zoological foundation for the clinical study of bladder pain syndrome, and to further guide clinical treatment. Methods: Thirty-two 8-week-old SD rats were randomly divided into 4 groups, including acute test group, acute control group, chronic test group, and chronic control group, with 8 rats in each group. The acute test group received intraperitoneal injection of cyclophosphamide 150 mg/kg immediately after the measurement of urodynamic data on the first day, and urodynamic examination was performed again 2 days later. After that, the rats were sacrificed to obtain bladder tissue. In the chronic test group, after measuring the baseline data of urodynamics on the first day, cyclophosphamide 75 mg/kg was intraperitoneally injected on the first, fourth, and seventh days, and the rats were sacrificed after measuring the urodynamic data again on the eighth day to obtain bladder tissue. The acute control group and the chronic control group were injected with the same amount of normal saline during intraperitoneal injection, and the urodynamic testing time point were consistent with the corresponding test groups. Histopathological changes of the bladder were assessed by HE staining. Results: In each acute and chronic group, there were no intragroup differences in baseline urodynamic levels between the test and control groups. The urodynamic maximum bladder volume was significantly reduced in the acute test group after administration(t=-2.961, P < 0.05), histologically, severe interstitial edema, obvious inflammatory cell infiltration, mucosal edema and submucosal hemorrhage, and partial urothelium were absent could be seen, which were consistent with acute cystitis performance. The urodynamic maximum bladder capacity was significantly reduced in the chronic test group after administration (t=-3.886, P < 0.05), and the bladder compliance was lower than that in the control group, but not significant, the histological manifestations were urothelial exfoliation, interstitial edema, submucosal hemorrhage, infiltration of inflammatory cells such as lymphocytes, and dense vascular distribution. Conclusion: In the acute test group, a single intraperitoneal injection of cyclophosphamide could induce acute bladder inflammation in the rats. In the chronic test group, repeated injections of cyclophosphamide could induce histological changes in chronic inflammation of chronic bladder pain syndrome in the rats. But the bladder function was not significantly impaired.
Lin ZHU , Wei-yu ZHANG , Ke-xin XU . Urodynamic and histological evaluation of cyclophosphamide-induced bladder pain syndrome in SD rats[J]. Journal of Peking University(Health Sciences), 2022 , 54(4) : 735 -740 . DOI: 10.19723/j.issn.1671-167X.2022.04.024
| 1 | Hakimi Z , Houbiers J , Pedersini R , et al. The burden of bladder pain in five European countries: a cross-sectional study[J]. Urology, 2017, 99 (1): 84- 91. |
| 2 | Hanno P , Lin A , Nordling J , et al. Bladder pain syndrome committee of the International Consultation on Incontinence[J]. Neurourol Urodyn, 2010, 29 (1): 191- 198. |
| 3 | Homma Y , Akiyama Y , Tomoe H , et al. Clinical guidelines for interstitial cystitis/bladder pain syndrome[J]. Int J Urol, 2020, 27 (7): 578- 589. |
| 4 | Akiyama Y , Hanno P . Phenotyping of interstitial cystitis/bladder pain syndrome[J]. Int J Urol, 2019, 26 (Suppl 1): 17- 19. |
| 5 | Chai TC , Russo A , Yu S , et al. Mucosal signaling in the bladder[J]. Auton Neurosci, 2016, 200 (10): 49- 56. |
| 6 | Karamali M , Shafabakhsh R , Ghanbari Z , et al. Molecular pathogenesis of interstitial cystitis/bladder pain syndrome based on gene expression[J]. J Cell Physiol, 2019, 234 (8): 12301- 12308. |
| 7 | Lee MH , Wu HC , Tseng CM , et al. Health education and symptom flare management using a video-based health system for caring women with BPS/IC[J]. Urology, 2018, 119 (9): 62- 69. |
| 8 | Crescenze IM , Tucky B , Li J , Moore C , et al. Efficacy, side effects, and monitoring of oral cyclosporine in interstitial cystitis-bladder pain syndrome[J]. Urology, 2017, 107 (9): 49- 54. |
| 9 | 杨进益, 魏伟, 叶林, 等. 膀胱水扩张后透明质酸钠灌注治疗间质性膀胱炎疗效分析[J]. 中华泌尿外科杂志, 2012, 33 (3): 219- 222. |
| 10 | Ryu CM , Yu HY , Lee HY , et al. Longitudinal intravital imaging of transplanted mesenchymal stem cells elucidates their functional integration and therapeutic potency in an animal model of interstitial cystitis/bladder pain syndrome[J]. Theranostics, 2018, 8 (20): 5610- 5624. |
| 11 | Lv YS , Yao YS , Rong L , et al. Intravesical hyaluronidase causes chronic cystitis in a rat model: a potential model of bladder pain syndrome/interstitial cystitis[J]. Int J Urol, 2014, 21 (6): 601- 607. |
| 12 | Mills KA , Chess-Williams R , McDermott C . Novel insights into the mechanism of cyclophosphamide-induced bladder toxicity: chloroacetaldehyde's contribution to urothelial dysfunction in vitro[J]. Arch Toxicol, 2019, 93 (11): 3291- 3303. |
| 13 | de Oliveira MG , Mónica FZ , Calmasini FB , et al. Deletion or pharmacological blockade of TLR4 confers protection against cyclophosphamide-induced mouse cystitis[J]. Am J Physiol Renal Physiol, 2018, 315 (3): 460- 468. |
| 14 | Augé C , Gamé X , Vergnolle N , et al. Characterization and validation of a chronic model of cyclophosphamide-induced interstitial cystitis/bladder pain syndrome in rats[J]. Front Pharmacol, 2020, 11 (8): 1305. |
| 15 | Yang W , Yaggie RE , Jiang MC , et al. Acyloxyacyl hydrolase modulates pelvic pain severity[J]. Am J Physiol Regul Integr Comp Physiol, 2018, 314 (3): 353- 365. |
| 16 | Lee UJ , Ackerman AL , Wu A , Zhang R , et al. Chronic psychological stress in high-anxiety rats induces sustained bladder hyperalgesia[J]. Physiol Behav, 2015, 139 (2): 541- 548. |
| 17 | Akiyama Y , Luo Y , Hanno PM , et al. Interstitial cystitis/bladder pain syndrome: the evolving landscape, animal models and future perspectives[J]. Int J Urol, 2020, 27 (6): 491- 503. |
| 18 | Birder L , Andersson KE . Animal modelling of interstitial cystitis/bladder pain syndrome[J]. Int Neurourol J, 2018, 22 (Suppl 1): 3- 9. |
/
| 〈 |
|
〉 |